Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Epidemiology of Epidemic Ebola Virus Disease in Conakry and Surrounding Prefectures, Guinea, 2014-2015.

Rico A, Brody D, Coronado F, Rondy M, Fiebig L, Carcelen A, Deyde VM, Mesfin S, Retzer KD, Bilivogui P, Keita S, Dahl BA.

Emerg Infect Dis. 2016 Feb;22(2):178-83. doi: 10.3201/eid2202.151304.

2.

Strengthening HIV surveillance in the antiretroviral therapy era: rationale and design of a longitudinal study to monitor HIV prevalence and incidence in the uMgungundlovu District, KwaZulu-Natal, South Africa.

Kharsany AB, Cawood C, Khanyile D, Grobler A, Mckinnon LR, Samsunder N, Frohlich JA, Abdool Karim Q, Puren A, Welte A, George G, Govender K, Toledo C, Chipeta Z, Zembe L, Glenshaw MT, Madurai L, Deyde VM, Bere A.

BMC Public Health. 2015 Nov 20;15:1149. doi: 10.1186/s12889-015-2179-2.

3.

Monitoring seasonal influenza A evolution: rapid 2009 pandemic H1N1 surveillance with an reverse transcription-polymerase chain reaction/electro-spray ionization mass spectrometry assay.

Jeng K, Massire C, Zembower TR, Deyde VM, Gubareva LV, Hsieh YH, Rothman RE, Sampath R, Penugonda S, Metzgar D, Blyn LB, Hardick J, Gaydos CA.

J Clin Virol. 2012 Aug;54(4):332-6. doi: 10.1016/j.jcv.2012.05.002. Epub 2012 Jun 4.

4.

Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009.

Chen LF, Dailey NJ, Rao AK, Fleischauer AT, Greenwald I, Deyde VM, Moore ZS, Anderson DJ, Duffy J, Gubareva LV, Sexton DJ, Fry AM, Srinivasan A, Wolfe CR.

J Infect Dis. 2011 Mar 15;203(6):838-46. doi: 10.1093/infdis/jiq124.

5.

RT-PCR/electrospray ionization mass spectrometry approach in detection and characterization of influenza viruses.

Deyde VM, Sampath R, Gubareva LV.

Expert Rev Mol Diagn. 2011 Jan;11(1):41-52. doi: 10.1586/erm.10.107. Review.

PMID:
21171920
6.

Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.

Gubareva LV, Trujillo AA, Okomo-Adhiambo M, Mishin VP, Deyde VM, Sleeman K, Nguyen HT, Sheu TG, Garten RJ, Shaw MW, Fry AM, Klimov AI.

Antivir Ther. 2010;15(8):1151-9. doi: 10.3851/IMP1678.

PMID:
21149922
7.

Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010.

Sheu TG, Fry AM, Garten RJ, Deyde VM, Shwe T, Bullion L, Peebles PJ, Li Y, Klimov AI, Gubareva LV.

J Infect Dis. 2011 Jan 1;203(1):13-7. doi: 10.1093/infdis/jiq005.

8.

Genomic signature-based identification of influenza A viruses using RT-PCR/electro-spray ionization mass spectrometry (ESI-MS) technology.

Deyde VM, Sampath R, Garten RJ, Blair PJ, Myers CA, Massire C, Matthews H, Svoboda P, Reed MS, Pohl J, Klimov AI, Gubareva LV.

PLoS One. 2010 Oct 12;5(10):e13293. doi: 10.1371/journal.pone.0013293.

9.

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses.

Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Jun;54(6):2517-24. doi: 10.1128/AAC.01739-09. Epub 2010 Mar 29.

10.

Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.

Okomo-Adhiambo M, Demmler-Harrison GJ, Deyde VM, Sheu TG, Xu X, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 May;54(5):1834-41. doi: 10.1128/AAC.01608-09. Epub 2010 Mar 1.

11.

Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing.

Deyde VM, Sheu TG, Trujillo AA, Okomo-Adhiambo M, Garten R, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2010 Mar;54(3):1102-10. doi: 10.1128/AAC.01417-09. Epub 2009 Dec 22.

12.

Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.

Okomo-Adhiambo M, Nguyen HT, Sleeman K, Sheu TG, Deyde VM, Garten RJ, Xu X, Shaw MW, Klimov AI, Gubareva LV.

Antiviral Res. 2010 Feb;85(2):381-8. doi: 10.1016/j.antiviral.2009.11.005. Epub 2009 Nov 13.

PMID:
19917319
13.

Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.

Sheu TG, Deyde VM, Garten RJ, Klimov AI, Gubareva LV.

Antiviral Res. 2010 Feb;85(2):354-60. doi: 10.1016/j.antiviral.2009.10.022. Epub 2009 Nov 1.

PMID:
19887086
14.

Influenza genome analysis using pyrosequencing method: current applications for a moving target.

Deyde VM, Gubareva LV.

Expert Rev Mol Diagn. 2009 Jul;9(5):493-509. doi: 10.1586/erm.09.21. Review.

PMID:
19580433
15.

Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method.

Deyde VM, Nguyen T, Bright RA, Balish A, Shu B, Lindstrom S, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2009 Mar;53(3):1039-47. doi: 10.1128/AAC.01446-08. Epub 2009 Jan 5.

16.

Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt.

Earhart KC, Elsayed NM, Saad MD, Gubareva LV, Nayel A, Deyde VM, Abdelsattar A, Abdelghani AS, Boynton BR, Mansour MM, Essmat HM, Klimov A, Shuck-Lee D, Monteville MR, Tjaden JA.

J Infect Public Health. 2009;2(2):74-80. doi: 10.1016/j.jiph.2009.04.004. Epub 2009 May 27.

17.

Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.

Deyde VM, Okomo-Adhiambo M, Sheu TG, Wallis TR, Fry A, Dharan N, Klimov AI, Gubareva LV.

Antiviral Res. 2009 Jan;81(1):16-24. doi: 10.1016/j.antiviral.2008.08.008. Epub 2008 Oct 7.

PMID:
18835410
18.

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.

19.

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.

Deyde VM, Xu X, Bright RA, Shaw M, Smith CB, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI.

J Infect Dis. 2007 Jul 15;196(2):249-57. Epub 2007 Jun 7.

PMID:
17570112
20.

Crimean-Congo hemorrhagic fever virus genomics and global diversity.

Deyde VM, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST.

J Virol. 2006 Sep;80(17):8834-42.

21.

Interactions and trafficking of Andes and Sin Nombre Hantavirus glycoproteins G1 and G2.

Deyde VM, Rizvanov AA, Chase J, Otteson EW, St Jeor SC.

Virology. 2005 Jan 20;331(2):307-15.

22.

Andes virus stimulates interferon-inducible MxA protein expression in endothelial cells.

Khaiboullina SF, Rizvanov AA, Deyde VM, St Jeor SC.

J Med Virol. 2005 Feb;75(2):267-75.

PMID:
15602733
23.

HbHope/HbS and HbS/beta-thal double compound heterozygosity in a Mauritanian family: clinical and biochemical studies.

Deyde VM, Lo BB, Aw T, Fattoum S.

Ann Hematol. 2003 Jul;82(7):423-6. Epub 2003 May 23.

PMID:
12764548
24.

Hemoglobin A2' (HbA2delta') in the Mauritanian population: first results of a preliminary survey.

Deyde VM, Fattoum S, Lo BB, Plaseska D, Efremov GD.

Ann Hematol. 2002 Jul;81(7):386-8. Epub 2002 Jun 5.

PMID:
12185509
25.

Epidemiological profile of hemoglobinopathies in the Mauritanian population.

Deyde VM, Lo BB, Khalifa IO, Ly B, Ball A, Fattoum S.

Ann Hematol. 2002 Jun;81(6):320-1. Epub 2002 May 17.

PMID:
12107561

Supplemental Content

Loading ...
Support Center